See what questions
a doctor would ask.
1 in 6 US men will be diagnosed with prostate cancer each year. Prostate cancer is believed to start with small changes in the size of the prostate gland cells - prostatic intraepithelial neoplasia. The bigger the changes, the higher the chance that cancer is present. Researchers are focusing on delivering an earlier diagnosis for this cancer with an unknown cause. Age is a risk factor for prostate cancer but exercise, vitamin E and a diet high in vegetables, fruits and grains can lower the risk. A study involving 334 men assessed the treatment benefits of the drug combination Taxotere and estramustine. The subjects receiving combination drugs lived 20% longer and had their cancer growth halved compared to those with standard chemotherapy. Side effects included nausea, fatigue, hair loss, infections, blood clots and lower blood count. The incidence of side effects was greater but the death rate did not increase. The drug combination is still awaiting FDA approval.
Source: summary of medical news story as reported by News 8 Austin
About: Drug combination may increase prostate cancer survival
Date: 11 December 2004
Source: News 8 Austin
http:/ This summary article refers to the following medical categories:
Related Medical Topics
More News Topics
This summary article refers to the following medical categories:
Search Specialists by State and City